Bohlin Garen G

Bohlin Garen G is listed in filings as Director at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI) and Collegium Pharmaceutical, Inc. (COLL). The current snapshot covers public activity from May 19, 2025 to May 26, 2026. Reported amounts are shown as $323.5K to $20.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.